Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Establishment Labs Holdings Inc (ESTA)

Establishment Labs Holdings Inc (ESTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,024,908
  • Shares Outstanding, K 29,321
  • Annual Sales, $ 211,080 K
  • Annual Income, $ -51,060 K
  • EBIT $ -39 M
  • EBITDA $ -29 M
  • 60-Month Beta 0.91
  • Price/Sales 9.78
  • Price/Cash Flow N/A
  • Price/Book 86.89

Options Overview Details

View History
  • Implied Volatility 64.06% (-2.21%)
  • Historical Volatility 46.94%
  • IV Percentile 36%
  • IV Rank 21.27%
  • IV High 123.47% on 04/08/25
  • IV Low 48.01% on 06/12/25
  • Expected Move (DTE 10) 3.66 (5.47%)
  • Put/Call Vol Ratio 0.33
  • Today's Volume 4
  • Volume Avg (30-Day) 600
  • Put/Call OI Ratio 0.76
  • Today's Open Interest 27,685
  • Open Int (30-Day) 32,247
  • Expected Range 63.16 to 70.47

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 9 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/26
See More
  • Average Estimate -0.28
  • Number of Estimates 2
  • High Estimate -0.16
  • Low Estimate -0.41
  • Prior Year -0.70
  • Growth Rate Est. (year over year) +60.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
65.00 +3.51%
on 02/24/26
83.31 -19.24%
on 02/25/26
-5.30 (-7.30%)
since 02/10/26
3-Month
63.00 +6.79%
on 01/27/26
83.31 -19.24%
on 02/25/26
-5.18 (-7.15%)
since 12/10/25
52-Week
26.56 +153.31%
on 04/09/25
83.31 -19.24%
on 02/25/26
+30.59 (+83.37%)
since 03/10/25

Most Recent Stories

More News
Establishment Labs Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Guidance

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced...

ESTA : 66.36 (-3.91%)
Establishment Labs Announces Leadership Transition to Support Next Phase of Growth

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced...

GCO : 26.85 (+3.72%)
ESTA : 66.36 (-3.91%)
Establishment Labs to Present at TD Cowen's 46th Annual Health Care Conference

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced...

ESTA : 66.36 (-3.91%)
Establishment Labs to Announce Fourth Quarter 2025 Financial Results on February 24

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to...

ESTA : 66.36 (-3.91%)
Establishment Labs Announces Preliminary Unaudited Financial Results for Fourth Quarter and Fiscal Year 2025

Revenue for the quarter ended December 31, 2025 is expected to be between $64.0 million and $65.0 million, including between $17.0 million and $17.5 million from Motiva sales in the United States. ...

ESTA : 66.36 (-3.91%)
Establishment Labs to Present at 44th Annual J.P. Morgan Healthcare Conference

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced...

ESTA : 66.36 (-3.91%)
Establishment Labs Submits to FDA for Approval of Motiva Implants in Breast Reconstruction

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced...

ESTA : 66.36 (-3.91%)
Establishment Labs to Present at Jefferies London Healthcare Conference

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced...

ESTA : 66.36 (-3.91%)
Establishment Labs Reports Third Quarter 2025 Financial Results

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, today announced...

ESTA : 66.36 (-3.91%)
Establishment Labs to Announce Third Quarter 2025 Financial Results on November 5

Establishment Labs Holdings Inc. (NASDAQ: ESTA), a global medical technology company dedicated to improving women’s health and wellness, principally in breast aesthetics and reconstruction, plans to...

ESTA : 66.36 (-3.91%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Establishment Labs Holdings Inc. is a medical technology company. It focuses on designing, developing, manufacturing and marketing portfolio of silicone gel-filled breast implants ae well as body shaping implants. The company's brand consists of Motiva Implants(R) and MotivaImagine (R) platform. Its...

See More

Key Turning Points

3rd Resistance Point 75.54
2nd Resistance Point 73.02
1st Resistance Point 71.04
Last Price 66.36
1st Support Level 66.54
2nd Support Level 64.02
3rd Support Level 62.04

See More

52-Week High 83.31
Last Price 66.36
Fibonacci 61.8% 61.63
Fibonacci 50% 54.93
Fibonacci 38.2% 48.24
52-Week Low 26.56

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar